The TMC team is led from our UK offices by the company's founders
Julie Matthews - Chief Executive Officer and VP Operations
Trained in microbiology, Julie ran an academic hospital research laboratory in Cambridge (UK) prior to joining Warner Lambert Clinical Development Group in 1986, where she ultimately became International Therapy Area Director. She then joined Rhone Poulenc Rorer in France, where she was involved first in oncology clinical development, and subsequently as Head of Anti-infectives Clinical Development.
Julie then joined Orphan Europe in Paris as Head of Clinical Development and Regional Business Manager, before going on to set up and run the company's UK affiliate, as General Manager responsible for drug and business development, regulatory affairs, sales and marketing. Julie started TMC in the year 2000.
Work for usDr Mike Matthews, MB ChB - Chief Medical Officer
After taking his medical degree at the University of Birmingham (UK) Mike worked in the UK Health and Safety Executive in infection control in hospitals and research labs, before joining the pharmaceutical industry in 1986. Since then, he has worked with ICI Pharmaceuticals HQ (now AstraZeneca) in the UK; Adelphi Communications (UK); Sanofi Recherche HQ (France); ADIS International (UK); ICON Clinical Research (as Director of Medical Affairs, Europe, based in the UK). Mike has also acted as an independent consultant to both major pharmaceutical and niche biotech companies. Mike joined TMC in 2001.
